Multiplex genetic testing, including both moderate- and high-penetrance genes for cancer susceptibility, is associated with greater uncertainty than traditional testing, presenting challenges to ...
VANCOUVER, Oct. 11, 2017 /PRNewswire/ - Vanrx Pharmasystems has released Manufacturing Injectables in the Multiplex, a white paper that describes a strategy to achieve flexibility and scale in ...
The risks, benefits, and utilities of multiplex panels for breast cancer susceptibility are unknown, and new counseling and informed consent models are needed. We sought to obtain patient feedback and ...
Leading multiplex chain PVR Ltd is adopting a multi-pronged strategy of tapping into micro-markets in big cities and at the same time it is entering new tier-3 and tier-4 territories through its ...